2003
DOI: 10.1046/j.1464-410x.2003.04496.x
|View full text |Cite
|
Sign up to set email alerts
|

Biodegradable urethral stents

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
16
0

Year Published

2006
2006
2024
2024

Publication Types

Select...
5
3
2

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(17 citation statements)
references
References 53 publications
1
16
0
Order By: Relevance
“…Biodegradable stents, drug-eluting stents, or radioisotopefilled balloon dilation are under investigation to prevent tissue hyperplasia [13][14][15]. For urethral stents, biodegradable stents will obviate the need for removal, and drugeluting stents or radioisotope-filled balloon dilation will make removal easier.…”
Section: Discussionmentioning
confidence: 99%
“…Biodegradable stents, drug-eluting stents, or radioisotopefilled balloon dilation are under investigation to prevent tissue hyperplasia [13][14][15]. For urethral stents, biodegradable stents will obviate the need for removal, and drugeluting stents or radioisotope-filled balloon dilation will make removal easier.…”
Section: Discussionmentioning
confidence: 99%
“…The ''proof-of-concept'' of biodegradable urethral stents should be credited to Torma¨la¨and co-workers in the early 1990s in Finland. After extensive experience gathered on the usage of biodegradable polymers as orthopedic fixation devices, the first biodegradable urethral stent made of selfreinforced poly(L-lactic acid) was tested in rabbits in 1993, 70 but still today, concerns about the true benefits of the employment of urethral stents, either permanent or temporary, exist among urologists. 47 Nevertheless, the group has published innumerable experimental studies, either in vivo or in vitro, regarding different aspects of biodegradable stent technology that reach far beyond the urologic application, such as e.g.…”
Section: Absorbable Polymer Stentsmentioning
confidence: 99%
“…The failure criteria for maximum strength as a function of degradation time have traditionally been modeled according to a first order kinetics. Many examples of this kind of design challenge can be found in the medical field, ranging from biodegradable sutures [19], pins and screws for orthopedic surgery [27], local drug delivery devices [18], tissue engineering scaffolds [20], biodegradable ligaments [37], biodegradable endovascular [10] and urethral stents [31]. [6] In this work, hyper elastic constitutive models, such as the Neo-Hokean, the MooneyRivlin modified and the second reduced order will also be discussed.…”
Section: Introductionmentioning
confidence: 99%